Sector Expert: Pierre Labbé

IMV Inc.



Recent Interviews

Cancer in the Crosshairs: IMV Looks to Deliver Immunotherapy a New Way (5/16/18)
Stem cell manipulation

In this interview with The Life Sciences Report, IMV Inc.'s CEO Fred Ors and Pierre Labbè, chief financial officer, describe the innovative immunotherapy platform technology that has attracted partnerships with big pharma, prompted reorganization of the company, and holds long-term promise for cancer patients.



Due to permission requirements, not all quotes are shown.